Tags: Drug.
Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAPIn 2003 it failed a phase II clinical trial for metastatic colorectal cancer.
Loading...
This page contains content from the copyrighted Wikipedia article "Sibrotuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.